GSK to acquire Sierra Oncology for US $1.9bn
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
These melas serve as platforms to attract thousands of people to avail quality healthcare services along with essential medicines and diagnostic services
Dr. Mansukh Mandaviya launches a quarterly report on AB-HWCs, Guidelines on Human resources for health, Public Health Management Cadre’ Guidance for implementation and Indian Public Health Standards Guidelines; interacts with healthcare workers from across the country
Ocular hypertension affects over 5% of all adults; the eye does not properly drain fluid, causing eye pressure to build up
Parkinson’s is not limited to old people, even youngsters can suffer from this disease
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
The total investment is in the region of Rs 200 crore
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
The peptide-based vaccine induces a t cell-dependent response
Lidocaine and Prilocaine Cream USP, 2.5%/2.5% has an estimated market size of US $ 29 million for twelve months ending Dec. 2021 according to IQVIA
Subscribe To Our Newsletter & Stay Updated